SBI Securities
BIOA icon

SBI Securities’s BioAge Labs BIOA Stock Holding History

SBI Securities’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.11K Buy
1,003
+999
+24,975% +$13.8K ﹤0.01% 2042
2026
Q2 		$98 Buy
+4
New +$72 ﹤0.01% 3518

Other funds holding BIOA

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
GF Fund Management
GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
True Wealth Design
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

SBI Securities's BIOA Position: Q3 2026 in Review

SBI Securities increased its BioAge Labs (BIOA) stake by 24,975% in Q3 2026, buying an estimated $13.8K and bringing the position to 1,003 shares worth $7.11K. The position accounts for ﹤0.01% of the portfolio, ranked #2042.

SBI Securities first reported a position in BIOA in Q2 2026 and has held it in 2 quarters since. 15 funds tracked by Wall St. Rank hold BIOA as of Q3 2026.

  • SBI Securities held 1,003 shares of BioAge Labs worth $7.11K as of Q3 2026.
  • SBI Securities bought 999 BioAge Labs shares in Q3 2026, an estimated $13.8K.
  • BioAge Labs made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #2042 holding.
  • SBI Securities first reported a position in BioAge Labs in Q2 2026 and has held it in 2 quarters since.
  • 15 funds tracked by Wall St. Rank held BioAge Labs as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.